JUBILANT PHARMOVA
Back to Balance Sheet
|
JUBILANT PHARMOVA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4,006 Cr | ₹3,765 Cr | ₹2,922 Cr | ₹2,973 Cr | ₹4,088 Cr |
What is the latest Total Non-Current Liabilities ratio of JUBILANT PHARMOVA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹4,006 Cr |
Mar2023 | ₹3,765 Cr |
Mar2022 | ₹2,922 Cr |
Mar2021 | ₹2,973 Cr |
Mar2020 | ₹4,088 Cr |
How is Total Non-Current Liabilities of JUBILANT PHARMOVA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4,006 Cr | 6.39 | |
Mar2023 | ₹3,765 Cr | 28.87 | |
Mar2022 | ₹2,922 Cr | -1.73 | |
Mar2021 | ₹2,973 Cr | -27.27 | |
Mar2020 | ₹4,088 Cr | - |
Compare Total Non-Current Liabilities of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹13,906.9 Cr | -2.6% | -4.5% | 35% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,379.0 Cr | 0.8% | 7.2% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,420.0 Cr | 0.7% | 11% | 53.3% | Stock Analytics | |
CIPLA | ₹122,010.0 Cr | -2% | 4.6% | 10.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,634.0 Cr | -1.6% | 2.8% | 24.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,788.5 Cr | -1.4% | 0.7% | -5.5% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -2.6% |
-4.5% |
35% |
SENSEX | 0.5% |
4.2% |
8% |
You may also like the below Video Courses